Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.
VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a dynamic holding company focused on innovative life sciences and wellness solutions, is ...
Opinion
From Boring to Brilliant: How Reimagining USPTO Fee Structure Is Central to U.S. Economic Security
Howard Lutnick has been universally criticized by industry for his reported proposal to tax patent values and revenue share with universities. But Lutnick is absolutely right about the problem. Here's ...
SINGAPORE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ESGL Holdings Limited (NASDAQ: ESGL), a leading carbon neutral, innovative enviro-tech company regenerating industrial waste into circular products, ...
STAMFORD, Conn. — In The Car, LLC., an embedded digital-first insurance platform, today announced that it has filed a U.S. provisional patent application for its innovative technology that delivers ...
ORLANDO - Nutriband Inc. (NASDAQ:NTRB), a pharmaceutical company showing strong momentum with a 56.8% price return over the past six months according to InvestingPro data, announced Wednesday it has ...
The U.S. Patent and Trademark Office (USPTO) published a Federal Register Notice today launching the Streamlined Claim Set ...
Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the filing of a provisional patent application with the U.S. Patent and Trademark Office to expand ...
Trust Stamp (Nasdaq: IDAI) announced that the United States Patent and Trademark Office (“USPTO”) has issued a notice of allowance in respect of Non-Provisional Patent Application No. 18/145,470 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback